Creative Realities, Inc. Warrant
CREXW
CREXW was delisted on the 17th of November, 2023.
7 hedge funds and large institutions have $9.19K invested in Creative Realities, Inc. Warrant in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
46% less capital invested
Capital invested by funds: $17K → $9.19K (-$7.81K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$605 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$339 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$294 |
| 3 |
BA
Bard Associates
Chicago,
Illinois
|
-$45 |
CREXW Hedge Fund Activity: Q4 2022 in Review
7 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Creative Realities, Inc. Warrant (CREXW) for Q4 2022, worth a combined $9.19K — down 46% from $17K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new CREXW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 4 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $605. The largest seller was UBS Group, cutting an estimated $339.
- 7 institutional investors held Creative Realities, Inc. Warrant (CREXW) as of Q4 2022, up from 6 in Q3 2022.
- Funds reported $9.19K of Creative Realities, Inc. Warrant stock for Q4 2022, down 46% quarter-over-quarter.
- 1 fund opened new Creative Realities, Inc. Warrant positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest Creative Realities, Inc. Warrant buyer in Q4 2022 was Susquehanna International Group, an estimated $605 added.
- The largest Creative Realities, Inc. Warrant seller in Q4 2022 was UBS Group, an estimated $339 sold.
Based on aggregated 13F filings for Q4 2022.